Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1986-04-30
1988-03-08
Phillips, Delbert R.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
530323, 530330, 530332, A61K 3743, C07K 706, C07K 702
Patent
active
047299851
ABSTRACT:
A series of novel polypeptide derivatives, containing 5-amino-2,5-disubstituted-4-hydroxypentanoic acid residues, which are useful for inhibiting the angiotensinogen-cleaving action of the enzyme renin. Particularly valuable precursors for many of these compounds are certain other 5-amino-2,5-disubstituted-4-hydroxypentanoic acid derivatives.
REFERENCES:
patent: 4163676 (1981-09-01), Fuhrer et al.
patent: 4424207 (1984-01-01), Szelke et al.
patent: 4478826 (1984-10-01), Veber et al.
Chem. Abstr., vol. 101:125684m, (1984), for Rich et al., Pept.:Struct. Funct., Proc. Am. Pept. Symp. 8th, 1983, 511-520.
Rich, J. Med. Chem., 28, 263-273, (1985).
Holladay et al., Tetrahedron Letters, 24, 4401-4404, (1983).
Evans et al., J. Org. Chem., 50, 4615-4625, (1985); previously cited as Chem. Abstr. 103:196413z.
Bindra Jasjit S.
Kleinman Edward F.
Rosati Robert L.
Blackwood Robert K.
Frost Albert E.
Pfizer Inc.
Phillips Delbert R.
Richardson Peter C.
LandOfFree
Renin inhibitors containing 5-amino-2,5-disubstituted-4-hydroxyp does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Renin inhibitors containing 5-amino-2,5-disubstituted-4-hydroxyp, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Renin inhibitors containing 5-amino-2,5-disubstituted-4-hydroxyp will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-231475